Stem Cell Transplantation for Stiff Person Syndrome (SPS)

NCT02282514 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

23

Enrollment

OTHER

Sponsor class

Stopped Could not predict who would respond, relapse or go into remission

Conditions

Stiff-Person Syndrome

Interventions

BIOLOGICAL: Autologous Hematopoietic Stem Cells
DRUG: Cyclophosphamide
DRUG: Mesna
DRUG: rATG
DRUG: Methylprednisolone
DRUG: G-CSF
DRUG: Rituxan

Sponsor

Northwestern University